This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Impact Therapeutics, Inc.. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2022
Title: Xiuhua Hu: Innovator in Pharmaceutical Research
Introduction
Xiuhua Hu is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds. With a total of 4 patents to his name, Hu is recognized for his innovative approaches to drug discovery.
Latest Patents
One of Hu's latest patents is focused on 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors. This patent discloses the use of these compounds, represented by the Formula (I), for therapeutic applications. The research highlights the potential of these compounds in treating various diseases, showcasing Hu's commitment to advancing medical science.
Career Highlights
Hu is currently associated with Impact Therapeutics, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work has garnered attention in the scientific community, and he is known for his dedication to improving patient outcomes through research.
Collaborations
Some of Hu's notable coworkers include Sui Xiong Cai and Ye Edward Tian, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Xiuhua Hu's contributions to pharmaceutical research and his innovative patents underscore his role as a leading inventor in the field. His work continues to inspire advancements in drug development and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile